You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 4, 2024

CLINICAL TRIALS PROFILE FOR FAMOTIDINE AND IBUPROFEN


✉ Email this page to a colleague

« Back to Dashboard


All Clinical Trials for FAMOTIDINE AND IBUPROFEN

Trial ID Title Status Sponsor Phase Start Date Summary
NCT00450216 ↗ Efficacy and Safety Study of HZT-501 in Subjects Requiring Nonsteroidal Anti-Inflammatory Drug (NSAID) Treatment Completed Horizon Pharma Ireland, Ltd., Dublin Ireland Phase 3 2007-03-01 The purpose of this study is to evaluate whether HZT-501 is effective in reducing the rate of development of ibuprofen-associated ulcers in patients who require long-term daily use of ibuprofen.
NCT00450658 ↗ Efficacy and Safety Study of HZT-501 in Reducing the Risk of Ibuprofen-associated Ulcers Completed Horizon Pharma Ireland, Ltd., Dublin Ireland Phase 3 2007-03-01 The purpose of this study is to evaluate whether HZT-501 is effective in reducing the rate of development of ibuprofen-associated ulcers in patients who require long-term daily use of ibuprofen.
NCT00613106 ↗ Double-Blind Follow-on Safety Study of HZT-501 (Ibuprofen 800 mg/Famotidine 26.6 mg) in Subjects Who Have Completed Participation in HZ-CA-301 (NCT00450658) or HZ-CA-303 (NCT00450216) Completed Horizon Pharma Ireland, Ltd., Dublin Ireland Phase 3 2007-09-01 The purpose of this study is to evaluate the safety of long-term treatment with HZT-501.
>Trial ID >Title >Status >Phase >Start Date >Summary

Clinical Trial Conditions for FAMOTIDINE AND IBUPROFEN

Condition Name

Condition Name for FAMOTIDINE AND IBUPROFEN
Intervention Trials
Rheumatoid Arthritis 2
Chronic Low Back Pain 2
Chronic Regional Pain Syndrome 2
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Condition MeSH

Condition MeSH for FAMOTIDINE AND IBUPROFEN
Intervention Trials
Osteoarthritis 2
Nociceptive Pain 2
Low Back Pain 2
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Locations for FAMOTIDINE AND IBUPROFEN

Trials by Country

Trials by Country for FAMOTIDINE AND IBUPROFEN
Location Trials
United States 9
This preview shows a limited data set
Subscribe for full access, or try a Trial

Trials by US State

Trials by US State for FAMOTIDINE AND IBUPROFEN
Location Trials
Texas 2
Pennsylvania 2
North Carolina 1
Massachusetts 1
Louisiana 1
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Progress for FAMOTIDINE AND IBUPROFEN

Clinical Trial Phase

Clinical Trial Phase for FAMOTIDINE AND IBUPROFEN
Clinical Trial Phase Trials
Phase 4 2
Phase 3 4
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Status

Clinical Trial Status for FAMOTIDINE AND IBUPROFEN
Clinical Trial Phase Trials
Completed 5
Terminated 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Sponsors for FAMOTIDINE AND IBUPROFEN

Sponsor Name

Sponsor Name for FAMOTIDINE AND IBUPROFEN
Sponsor Trials
Horizon Pharma Ireland, Ltd., Dublin Ireland 5
Pediatric Rheumatology Collaborative Study Group 1
Duke University 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Sponsor Type

Sponsor Type for FAMOTIDINE AND IBUPROFEN
Sponsor Trials
Industry 5
Other 2
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.